Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies.

Rheum Dis Clin North Am

Division of Gastroenterology and Hepatology, University of Tennessee Health Sciences Center, 1211 Union Avenue, Suite #460, Memphis, TN 38104, USA. Electronic address:

Published: February 2018

Although muscle weakness is the pathognomonic feature of idiopathic inflammatory myopathies, systemic organ involvement is not uncommon. The gastrointestinal and hepatic manifestations are well known. Oropharyngeal dysphagia is the most common gastrointestinal symptom and can be severe. Gastric and small intestinal motility disorders, including chronic intestinal pseudo-obstruction, celiac disease, and inflammatory bowel disease have been described. Comprehensive cancer screening is warranted soon after the diagnosis of inflammatory myopathies due to high risk of occult malignancies. Elevated aminotransferases may suggest muscular injury rather than hepatic dysfunction. Knowledge regarding systemic involvement of inflammatory myopathies can assist in timely diagnosis of these complex disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2017.09.006DOI Listing

Publication Analysis

Top Keywords

inflammatory myopathies
16
gastrointestinal hepatic
8
disease inflammatory
8
inflammatory
5
hepatic disease
4
myopathies
4
myopathies muscle
4
muscle weakness
4
weakness pathognomonic
4
pathognomonic feature
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!